February 20, 2017 2:21 PM ET


Company Overview of Acretia, Inc.

Key Executives for Acretia, Inc.

NameBoard RelationshipsTitleAge
Robert G. Urban Ph.d.No RelationshipsChief Executive Officer and President--
John A. Rocha No RelationshipsVice President of Finance--
Neal G. Anderson Ph.D.No RelationshipsHead of Manufacturing Chemicals--
William D. Kerns DVM, MS, DACVP32 RelationshipsHead of Preclinical and Regulatory--
Steven Lazar J.d.No RelationshipsHead of Intellectual Property--
View More Key Executives

Acretia, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Lee M. Nadler M.D. 153 RelationshipsDana-Farber Cancer Institute, Inc.69
Neal Rosen Ph.D., M.D. 102 RelationshipsBeiGene, Ltd.--
Samuel J. Danishefsky Ph.D. 63 RelationshipsCellceutix Corporation--
Dale L. Boger Ph.D. 19 RelationshipsNovasite Pharmaceuticals, Inc.--
Robin Polt Ph.d. 5 RelationshipsAcretia, Inc.--
View All Board Members

Acretia, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Acretia, Inc. CEO Compensation
Industry Average


Pain Therapeutics, Inc. Announces Resignation of Peter S. Roddy as Vice President, Chief Financial Officer and Secretary
February 17, 2017 2:01 PM ET
Dragonite International Limited Announces Appointment of Non-Executive Directors
February 17, 2017 10:28 AM ET
Wuyi International Pharmaceutical Company Limited Announces Executive Changes
February 17, 2017 9:08 AM ET
AcelRx Pharmaceuticals, Inc. Announces Management Changes
February 16, 2017 9:45 PM ET
Cocrystal Pharma, Inc. Announces Resignation of Walt A. Linscott as General Counsel and Secretary, Effective March 1, 2017
February 16, 2017 9:15 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acretia, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.